Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Guay

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Organic & Biomolecular Chemistry|November 3, 2023
Convenient route to Fmoc-homotyrosine <i>via</i> metallaphotoredox catalysis and its use in the total synthesis of anabaenopeptin cyclic peptidesChristopher Bérubé, Louis-David Guay, Tommy Fraser, et al.
Bioorganic & Medicinal Chemistry|August 1, 2021
Synthesis and biological evaluation of novel 1,4-benzodiazepin-3-one derivatives as potential antitumor agents against prostate cancerSimon Vézina-Dawod, Martin Perreault, Louis-David Guay, et al.
The International Journal of Biochemistry & Cell Biology|June 24, 2008
The strand separation and nuclease activities associated with YB-1 are dispensable for cisplatin resistance but overexpression of YB-1 in MCF7 and MDA-MB-231 breast tumor cells generates several chemoresistance signaturesDavid Guay, Audrey-Ann Evoy, Eric Paquet, et al.
European Journal of Medicinal Chemistry|January 1, 2026
Exploring the structure-activity relationship of brevibacillin: Discovery of synthetic analogues with an extended spectrum of activityLouis-David Guay, Florence Henley, Maxim Boucher, et al.
International Journal of Molecular Sciences|February 10, 2024
Antimicrobial Activity of Synthetic Enterocins A, B, P, SEK4, and L50, Alone and in Combinations, against <i>Clostridium perfringens</i>Sara García-Vela, Louis-David Guay, Md Ramim Tanver Rahman, et al.
Biomedical Engineering Online|September 12, 2012
Use of inert gas jets to measure the forces required for mechanical gene transfectionGuillaume Chouinard-Pelletier, Mathieu Leduc, David Guay, et al.
International Journal of Biological Macromolecules|September 20, 2024
Synthesis, antimicrobial activity, and mechanistic studies of enterocin DD14, a leaderless two-peptide bacteriocinYanath Belguesmia, Louis-David Guay, Radja Teiar, et al.
Molecular Cancer|November 29, 2011
NONO and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell linesSerges P Tsofack, Chantal Garand, Chris Sereduk, et al.
Human Gene Therapy|June 19, 2023
Genome Editing in Ferret Airway Epithelia Mediated by CRISPR/Nucleases Delivered with Amphiphilic Shuttle PeptidesMeihui Luo, Jia Ma, Xue Cheng, et al.
Probiotics and Antimicrobial Proteins|July 14, 2026
Comprehensive Phenotypic and Genomic Study for Understanding the Variability in Susceptibility of Listeria monocytogenes to AMPs and BacteriocinsOmar Fliss, Louis-David Guay, Nguyen Phuong Pham, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Organic & Biomolecular Chemistry|November 3, 2023
Convenient route to Fmoc-homotyrosine <i>via</i> metallaphotoredox catalysis and its use in the total synthesis of anabaenopeptin cyclic peptidesChristopher Bérubé, Louis-David Guay, Tommy Fraser, et al.
Bioorganic & Medicinal Chemistry|August 1, 2021
Synthesis and biological evaluation of novel 1,4-benzodiazepin-3-one derivatives as potential antitumor agents against prostate cancerSimon Vézina-Dawod, Martin Perreault, Louis-David Guay, et al.
The International Journal of Biochemistry & Cell Biology|June 24, 2008
The strand separation and nuclease activities associated with YB-1 are dispensable for cisplatin resistance but overexpression of YB-1 in MCF7 and MDA-MB-231 breast tumor cells generates several chemoresistance signaturesDavid Guay, Audrey-Ann Evoy, Eric Paquet, et al.
European Journal of Medicinal Chemistry|January 1, 2026
Exploring the structure-activity relationship of brevibacillin: Discovery of synthetic analogues with an extended spectrum of activityLouis-David Guay, Florence Henley, Maxim Boucher, et al.
International Journal of Molecular Sciences|February 10, 2024
Antimicrobial Activity of Synthetic Enterocins A, B, P, SEK4, and L50, Alone and in Combinations, against <i>Clostridium perfringens</i>Sara García-Vela, Louis-David Guay, Md Ramim Tanver Rahman, et al.
Biomedical Engineering Online|September 12, 2012
Use of inert gas jets to measure the forces required for mechanical gene transfectionGuillaume Chouinard-Pelletier, Mathieu Leduc, David Guay, et al.
International Journal of Biological Macromolecules|September 20, 2024
Synthesis, antimicrobial activity, and mechanistic studies of enterocin DD14, a leaderless two-peptide bacteriocinYanath Belguesmia, Louis-David Guay, Radja Teiar, et al.
Molecular Cancer|November 29, 2011
NONO and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell linesSerges P Tsofack, Chantal Garand, Chris Sereduk, et al.
Human Gene Therapy|June 19, 2023
Genome Editing in Ferret Airway Epithelia Mediated by CRISPR/Nucleases Delivered with Amphiphilic Shuttle PeptidesMeihui Luo, Jia Ma, Xue Cheng, et al.
Probiotics and Antimicrobial Proteins|July 14, 2026
Comprehensive Phenotypic and Genomic Study for Understanding the Variability in Susceptibility of Listeria monocytogenes to AMPs and BacteriocinsOmar Fliss, Louis-David Guay, Nguyen Phuong Pham, et al.
Pageof 3